Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
about
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic rangeA noninvasive method to measure splanchnic glucose uptake after oral glucose administrationPhysiological effects and therapeutic potential of proinsulin C-peptideProinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-proteinProinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cellsHyperinsulinemia after pancreatic transplantation. Prediction by a novel computer model and in vivo verification.Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplantsMetabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects.Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF ratsGlucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin.Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.The value of artificial beta cell in the management of insulinoma.Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitusBayesian functional integral method for inferring continuous data from discrete measurementsAssessment of the effects of insulin secretagogues in humans.A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.Splanchnic insulin metabolism in obesity. Influence of body fat distribution.Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistanceEpinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in manMechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defectChanges in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitusSerum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistanceRelationship between Body Mass Index, C-Peptide, and Delta-5-Desaturase Enzyme Activity Estimates in Adult MalesC-Peptide reduces mitochondrial superoxide generation by restoring complex I activity in high glucose-exposed renal microvascular endothelial cells.Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5-/- mice.Renoprotective effects of C-peptide in the Dahl salt-sensitive rat.The role of organelles in the chemical modification of the primary translation products of secretory proteins.Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog.Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans.Thyrotropin-releasing hormone in the systemic circulation of the neonatal rat is derived from the pancreas and other extraneural tissues.Kinetics of human connecting peptide in normal and diabetic subjects.Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a reviewEffect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipientsA profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation.C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat.
P2860
Q24563463-E4B0C66F-6B41-43ED-8220-0C43B122ECE4Q24629428-53736E73-936B-49E3-B06F-A3F4536EADBDQ27012286-9656B4EA-60FB-4C2E-9B3E-52E5CF39C7EFQ28360627-0C33E4D6-9D58-40E3-9946-CEBCE6A4EC8EQ28513872-2AAFBEE0-0878-4776-A0CC-8D47C2F04CE1Q30466678-D2C99E41-EDB9-46D4-994C-D2EA11E44787Q32063285-7AA9B4B2-8BE5-4B39-94D4-D8DF752F4158Q33738693-56022931-A93F-4881-A53F-837F5723682FQ33822392-393838CB-8D76-42FA-9968-F125D465EF77Q33889867-DD55452A-E8BB-4027-B034-A64D7FD668CBQ33900501-D577DDAC-94FC-4B97-819B-40BD834C9DA5Q34009469-0AB135D3-6219-4D59-8BE8-5072C5C64044Q34073469-F922E611-FCEC-4167-B23A-F196D225A7E4Q34112132-38AD741B-89B0-43D4-AF84-0899C74882B5Q34112186-EE825F9C-0CED-4924-81FF-76152C46BFA2Q34156249-2F3289CF-85BB-489C-AC9F-9D1F8F244109Q34166369-447ED81B-8966-4555-85A5-445FD823A028Q34220806-FA664F1A-EE39-4619-9970-FD57AB2B0311Q34430820-835085E3-2073-4596-8DD8-4A304D777BF1Q34551426-2FE53919-CA98-4590-8498-012EAB633207Q34577169-E311B5CE-7FEB-4682-8133-B57809253C4EQ34602608-F72C2580-4E04-43CE-8432-A42A1912782EQ34628137-A942E93C-513C-40FE-8ECD-401197580B2EQ35360786-073C11E4-6ED1-435C-9D51-16AE4E2888F4Q35682776-67582CA7-63FE-446B-8322-E5AED8A6EC7EQ35937827-D5FB8DAB-1004-4572-8BFB-12E0F7102263Q35972925-CDD48CE6-305A-45F1-AFEB-5CA9FF0EDB99Q36072433-EAF1B169-18FB-455E-A0A1-CB21790D5E27Q36237169-01F0FE3F-F017-4402-B631-7E3FF8456FEAQ36309482-2A2F71B3-82BF-4D0D-A62F-9E87FE4D2437Q36356972-F03C9121-26B2-4AA4-BD6F-74B0D5F3950BQ36477271-6B5A0A00-4E97-4153-8715-BF4E6F29B979Q36496369-74E1DB9D-015F-4EFA-B48F-F909A47D1400Q36996711-BACD33F9-F678-4E0B-BFF3-01CCC15383A7Q37030191-4171E76F-4850-40DB-AF9B-51EB8F8A61F9Q37051107-633662AA-BF34-432A-B849-F6EA1A88327CQ37070253-552EA5E0-D2EE-49D8-AB52-496D6F8C3DE4Q37072675-6DBA4E8E-4BAD-4E8D-AB64-8494CBB1B637Q37073146-680D500D-F0C8-480F-A1B5-C8BA1D5D10B7Q37282197-5DA6F17B-B7C0-4F7E-9CB9-B9F0F8C3549F
P2860
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
@en
type
label
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
@en
prefLabel
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
@en
P2093
P2860
P356
P1476
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
@en
P2093
Blackard WG
Horwitz DL
Rubenstein AH
P2860
P304
P356
10.1172/JCI108047
P407
P577
1975-06-01T00:00:00Z